
|Articles|July 17, 2012
Groups to CMS: Slow Down
Advertisement
Is the push to change how “dual eligibles” get their health care going too far, too fast?
That’s a question that’s beginning to be heard from lots of quarters — including the Medicare Payment Advisory Commission, the American Medical Association, some analysts and now at least one key lawmaker.
Read the full story:
Source: Politico
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
4
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
5













































